Researchers explore the optimal cost-benefit considerations of medical device cybersecurity risks.
Scholar argues for an optimal commercial space regulatory regime that balances innovation, responsibility, and security.
The federal government must step in to regulate an industry fraught with youth abuse.
Anti-abortion advocates take aim at FDA approval and regulation of the abortion drug mifepristone, threatening access nationwide.
Exploring FDA’s toolkit for encouraging study sponsors to meet diversity goals.
With cyberattacks on medical devices on the rise, scholars examine regulatory challenges and solutions.